Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

PMD
Psychemedics Corp.
stock NASDAQ

At Close
3/27/2023 3:04:30 PM EDT
5.15USD-0.194%(-0.01)0
0.00Bid   0.00Ask   0.00Spread IEX
Pre-market
1969-12-31
0.00USD-100.000%(-5.16)0
After-hours
3/22/2023 4:00:30 PM EDT
5.31USD-0.933%(-0.05)0
OverviewHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
29.070M
Headquarters
MA, USA
Industry
Diagnostics & Research
Next Earnings
2023-05-09 (42d)
Last Dividend
2023-03-300.070
Last Split
2002-08-011for4reverse
Related
RDNTDGXENZLHNEOXLV
PMD Stats
Avg. Vol. 10 Day
13,219
Avg. Vol. 30 Day
8,384
Dividend Yield
4.022%
Dividend Rate (ttm)
0.208
Next Dividend Date
2023-03-30
Employees
139
Market Cap
29,070,184
Shares Out.
5,644,696
Float
4,091,059
On/Off Exchange
69%/31%
6 Month Beta
0.15
1 Year Beta
0.26
2 Year Beta
0.30
3 Year Beta
0.05
52 Week Low
4.85
52 Week High
7.05
SMA50
5.68
SMA200
5.80
1 Week
-0.58%
1 Month
-8.53%
3 Month
+4.68%
6 Month
-18.64%
1 Year
-27.97%
2 Year
-18.25%
5 Year
-74.88%
Dec 10, 2021
05:00PM EST  Psychemedics Corporation (NASDAQ:PMD), the worlds largest provider of hair testing for drugs of abuse, today announced that it has declared a cash dividend of $0.05 per share to be paid on December 30th, 2021 to shareholders of record as of December 20th, 2021.   GlobeNewswire Inc
Nov 12, 2021
05:00PM EST  Psychemedics Corporation (NASDAQ:PMD), the worlds largest provider of hair testing for drugs of abuse, today announced financial results for the third quarter ended September 30, 2021.   GlobeNewswire Inc
Sep 23, 2021
08:49AM EDT  Peter H. Kamin On Sept. 23 Delivered Letter To Psychemedics Corp's Board Of Directors Stating That It Is Necessary For Psychemedics' Board To Consider Strategic Alternatives For The Benefit Of All Stockholders   Benzinga
Sep 8, 2021
07:32AM EDT  The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod   Benzinga
Aug 10, 2021
02:42PM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
More News
Profile
Psychemedics Corporation is the world's largest provider of hair testing for the detection of drugs of abuse. The Company's patented process is used by thousands of U.S. and international clients, including over 10% of the Fortune 500 companies, for pre-employment and random drug testing. Major police departments, Federal Reserve Banks, schools, and other public entities also rely on company's unique patented drug testing process. Psychemedics Corporation strongly believes its drug testing method to be superior to any other product currently in use, including traditional urine testing and other hair testing methods.

PMD Stock Summary

Psychemedics Corp. (NASDAQ:PMD) stock price today is $5.15, and today's volume is 0. PMD is down -0.194% today. The 30 day average volume is 8,384. PMD market cap is 29.070M with 5,644,696 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC